EVR - EVERCORE INC （）

https://www.investing.com/news/pro/evercore-isi-downgrades-qualtrics-to-in-line-432SI-3023100

Within its last year performance, AKRO rose by 172.10%, with highs and lows ranging from $54.88 to $7.52, whereas the simple moving average jumped by 61.43% in the last 200 days. On January 27, 2023, Morgan Stanley Upgraded Akero Therapeutics Inc. (NASDAQ: AKRO) to Overweight. A report published by Evercore ISI on September 14, 2022, […]

https://www.investing.com/news/pro/evercore-isi-upgrades-neurocrine-bio-to-outperform-we-believe-2023-ingrezza-guidance-will-prove-to-be-conservative-432SI-3021520

NEW YORK : OneSpan Inc, a U.S. cybersecurity tools vendor that has become the target of activist hedge funds such as Legion Partners Asset Management, is exploring options that include a sale of the company, people familiar with the matter said. OneSpan is working with investment bank Evercore Inc on a sa

OneSpan (OSPN) jumped 10% on a report that the cybersecurity firm is exploring options, including a possible sale.OneSpan (OSPN) is working with Evercore ISI on a sales process that…

Within its last year performance, AKRO rose by 172.10%, with highs and lows ranging from $54.88 to $7.52, whereas the simple moving average jumped by 61.43% in the last 200 days. On January 27, 2023, Morgan Stanley Upgraded Akero Therapeutics Inc. (NASDAQ: AKRO) to Overweight. A report published by Evercore ISI on September 14, 2022, […]

https://www.investing.com/news/pro/evercore-isi-upgrades-neurocrine-bio-to-outperform-we-believe-2023-ingrezza-guidance-will-prove-to-be-conservative-432SI-3021520

NEW YORK : OneSpan Inc, a U.S. cybersecurity tools vendor that has become the target of activist hedge funds such as Legion Partners Asset Management, is exploring options that include a sale of the company, people familiar with the matter said. OneSpan is working with investment bank Evercore Inc on a sa

OneSpan (OSPN) jumped 10% on a report that the cybersecurity firm is exploring options, including a possible sale.OneSpan (OSPN) is working with Evercore ISI on a sales process that…

(marketscreener.com) EXCLUSIVE-ONESPAN INC WORKING WITH EVERCORE INC TO EXPLORE A SALE - SOURCES https://www.marketscreener.com/news/latest/ONESPAN-INC-WORKING-WITH-EVERCORE-INC-TO-EXPLORE-A-SAL-8230--43141270/?

https://www.investing.com/news/pro/evercore-isi-removes-apple-from-tactical-outperform-list-432SI-2995180

Keefe, Bruyette & Woods boosted the price target for Evercore Inc. (NYSE: EVR ) from $132.5 to $137. Keefe, Bruyette & Woods analyst Matthew Moon maintained an Outperform rating. Evercore shares rose 1% to $133.07 on Thursday. UBS cut the price target for Humana Inc. (NYSE: HUM ) from $645 to $620. UBS analyst Kevin Caliendo maintained a Buy rating. Humana shares fell 2.2% to $501.83 on Thursday. Susquehanna boosted the price target for Alaska Air Group, Inc. (NYSE: ALK ) from $55 to $59. Susquehanna analyst Christopher Danely maintained a Positive rating. Alaska Air shares gained 0.6% to trade at $52.15 on Thursday. Baird raised the price target for O-I Glass, Inc. (NYSE: OI ) from $24 to $26.. … Full story available on Benzinga.com

BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc., (NASDAQGM: VERA , "Vera")), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its previously announced underwritten public offering of 14,285,715 shares of its Class A common stock at a price to the public of $7.00 per share. The gross proceeds to Vera from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $100.0 million. In addition, Vera has granted the underwriters a 30-day option to purchase up to an additional 2,142,857 shares of Class A common stock at the public offering price less underwriting discounts and commissions. The offering is expected to close on February 6, 2023, subject to satisfaction of customary closing conditions. J.P. Morgan, Cowen and Evercore ISI are acting as joint book-running managers for the proposed offering.

Evercore Inc. (NYSE:NYSE:EVR) Q4 2022 Earnings Conference Call February 1, 2022 8:00 AM ETCompany ParticipantsKaty Haber - Head of Investor Relations and ESGJohn Weinberg - Chairman and…

Evercore (EVR) Q4 earnings and revenue Wednesday each topped Wall Street expectations despite notable Y/Y weakness across the company''s investment banking and management…